mCSM-AB2: guiding rational antibody design using graph-based signatures. (2020)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/bioinformatics/btz779
PubMed Identifier: 31665262
Publication URI: http://europepmc.org/abstract/MED/31665262
Type: Journal Article/Review
Volume: 36
Parent Publication: Bioinformatics (Oxford, England)
Issue: 5
ISSN: 1367-4803